Editor-in-Chief, Deputy Editor 2017-2019

 

Editor-in-Chief:

Tom MOREELS

 

Deputy Editor:

Nicolas LANTHIER

 

Letter



Insulinoma and extreme obesity in a patient with MEN1 syndrome


Price: €10,00

We report a patient aged 16 experiencing headache, galactorrhea and ammenorrhea. Laboratory examination showed an increased prolactin (PRL) level (> 400 ng/mL ; normal range 5-30 ng/mL ) and computed tomography (CT) of pituitary gland revealed a tumor mass, 1.5 x 0.9 cm in size. Transnasal selective partial adenomectomy was performed, and postoperative excisional biopsy showed a prolactinoma. Postoperatively, she developed hypopituitarism, for which levothyroxin (100 μg/day) and hydrocortison (30 mg/day) replacement therapy were prescribed. [Product Details...]



Ornidazole-induced hepatitis


Price: €10,00

Ornidazole, a synthetic nitroimidazole derivative, is a commonly prescribed antiparasitic drug for parasitic infestations, including amoebiasis, giardiasis and Tricho - monas vaginalis. The drug is generally well tolerated. Hepatobiliary dysfunction associated with ornidazole has been reported infrequently (1-4). Here, we describe a Turkish female patient who developed hepatitis after ornidazole use. [Product Details...]



The prevalence of gallbladder polyps is higher in HBsAg positive population


Price: €10,00

In a hospital-based, cross-sectional study, we retrospectively analyzed the medical records of all the subjects undergoing self-referred health examination at one medical center located at Taichung city in Taiwan between 2000 and 2004. Excluding subjects with cholecystectomy, 3070 men (56.0%) and 2411 women (44.0%) were included in the study. Mean age was 49.2 ± 12.3 years (range from 20 to 87). Ultrasonographic findings showed a normal gallbladder in 4920 subjects (89.8%), polyps in 265 subjects (4.8%), stones in 278 subjects (5.1%), and mixed stones/polyps in 18 subjects (0.3%). Thus, the overall prevalence of gallbladder polyps was 5.1% [(265 + 18)/5481]. Data from these 283 subjects were used for further evaluation. [Product Details...]


  • «« Start
  • « Prev
  • 1
  • Next »
  • End »»
Results 1 - 3 of 3